Pathogenic variants in FBN2 may weaken microfibril structure or disrupt binding capability, subsequently weaken the elastic fiber and perturbate ECM-mediated signaling, which leads to the anomalies of CCA (Ratnapriya et al., 2014). Here, FBN2 is linked to congenital contractural arachnodactyly.